Literature DB >> 1711886

Selenium and Behçet's disease.

E Delilbaşi1, B Turan, E Yücel, R Saşmaz, A Işimer, A Sayal.   

Abstract

Behçet's disease is an inflammatory disorder of unknown etiology, characterized by recurrent oral and genital aphthous ulcers, ocular inflammation, and skin lesions of erythema nodosum and acneiform eruptions. Selenium (Se) affects all components of the immune system, i.e., the development and expression of nonspecific, humoral, and cell-mediated responses. In general, a deficiency in Se appears to result in immunosuppression, whereas supplementation with low doses of Se appears to result in augmentation and/or restoration of immunologic functions. In this study, the distribution of Se and IgG, IgM in serum were compared in samples from healthy adult control and Behçet's disease patients. The serum Se levels were measured by AA-30-40 Varian Spectra, and immunoglobulins were measured by immunodiffusion technique. The mean (SD) serum Se level of 54.24 +/- 8.06 ng/mL among Behçet's disease subjects was significantly different (P less than 0.01) from that in the control subjects (90.01 +/- 9.94 ng/mL). We also measured IgG and IgM as 10.01 +/- 2.74 mg/mL and 1.26 +/- 0.29 mg/mL, respectively for patients, and 15.08 +/- 4.73 mg/mL and 1.58 +/- 0.43 mg/mL for controls. The mean values of IgG and IgM for patients were significantly (P less than 0.05) different from the values of controls. It seems, therefore, that a deficiency in selenium impedes the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711886     DOI: 10.1007/bf02990459

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  19 in total

1.  The prevalence of Behçet's syndrome in a rural area in northern Turkey.

Authors:  S Yurdakul; I Günaydin; Y Tüzün; N Tankurt; H Pazarli; Y Ozyazgan; H Yazici
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

2.  The effect of selenium on phagocytosis in humans.

Authors:  E Greenman; M J Phillipich; C J Meyer; L J Charamella; N V Dimitrov
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

3.  Serum selenium in acute infections.

Authors:  K Sammalkorpi; V Valtonen; G Alfthan; A Aro; J Huttunen
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

Review 4.  Immunologic aspects of recurrent oral ulcers.

Authors:  T Lehner
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1972-01

5.  Microtubules in neutrophils of patients with Behçet's disease--immunofluorescence microscopic study.

Authors:  T Saga; H Matsuda; S Aso
Journal:  Jpn J Ophthalmol       Date:  1987       Impact factor: 2.447

Review 6.  Behçet's disease. New perspectives on an enigmatic syndrome.

Authors:  S J Arbesfeld; A K Kurban
Journal:  J Am Acad Dermatol       Date:  1988-11       Impact factor: 11.527

7.  Selenium and myocardial infarction: glutathione peroxidase in platelets.

Authors:  Y X Wang; K Böcker; H Reuter; J Kiem; K Kasperek; G V Iyengar; F Loogen; R Gross; L E Feinendegen
Journal:  Klin Wochenschr       Date:  1981-07-15

8.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex.

Authors:  B M Dworkin; W S Rosenthal; G P Wormser; L Weiss; M Nunez; C Joline; A Herp
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

Review 9.  Clinical aspects of selenium metabolism.

Authors:  H Zumkley
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

10.  Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.

Authors:  A P Wilson; J Efthimiou; D J Betteridge
Journal:  Eur J Clin Invest       Date:  1988-08       Impact factor: 4.686

View more
  1 in total

1.  Mineral status in selenium-deficient rats compared to selenium-sufficient rats fed vitamin-free casein-based or torula yeast-based diet.

Authors:  Z Zhu; M Kimura; Y Itokawa
Journal:  Biol Trace Elem Res       Date:  1993 May-Jun       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.